Murali Ramachandran insider trades
Murali Ramachandran has filed 3 Form 4s with the SEC that we hold, all for Kairos Pharma, LTD. (KAPA), as VP of Research and Development. Across all of them we count 1 purchase worth $318 and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 200 shares of Kairos Pharma, LTD. worth $318, dated 2024-11-25. The first filing on our record is dated 2024-11-25 and the latest 2025-11-26.
Kairos Pharma, LTD. (KAPA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-11-25 | P, purchase reported on Form 4 | 200 | $318 | 2024-11-25 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1870016) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms